Results 181 to 190 of about 92,443 (271)
Choledochojejunostomy—Its Ability to Control Chronic Recurring Pancreatitis
, 1955 Ralph F. Bowers
openalex +2 more sources
United European Gastroenterology Journal, EarlyView.ABSTRACT Background Vedolizumab is approved for the treatment of moderately to severely active Crohn's disease (CD). Real‐world evidence is essential for understanding the effectiveness and benefit–risk profile of vedolizumab outside clinical trial settings.
Alessandro Armuzzi +7 more
wiley +1 more source
Heterotopic pancreatic tissue masquerading as a neuroendocrine tumour
, 2022 ANZ Journal of Surgery, Volume 92, Issue 12, Page 3353-3355, December 2022.
Michalis Koullouros +3 more
wiley +1 more source
Sites of Pancreatic Duct Obstruction in Chronic Pancreatitis
, 1959 Alan P. Thal +2 more
openalex +2 more sources
United European Gastroenterology Journal, EarlyView.ABSTRACT This article guides the design and execution of successful collaborative randomized controlled trials (RCTs). Aimed at researchers looking to impact clinical practice, it highlights the advantages of RCTs over observational studies in driving clinical advancements.
Enrique de‐Madaria
wiley +1 more source
Etiologic Role of Acute Pancreatitis in the Production of Diabetes Mellitus [PDF]
, 1954 Paul L. Shallenberger, David F. Kapp
openalex +1 more source
Increased Early Post‐Discharge Mortality in Patients With Acute Pancreatitis
United European Gastroenterology Journal, EarlyView.ABSTRACT Background Emerging evidence suggests that individuals who recover from acute pancreatitis may face a significant risk of mortality during the early post‐discharge period. Despite these concerns, comprehensive population‐based studies on this issue are lacking. Objectives To study in‐hospital and post‐discharge mortality in patients with acute
Line Davidsen +4 more
wiley +1 more source